Phase III, Randomized, Placebo-Controlled Trial of CC-486 (Oral Azacitidine) in Patients With Lower-Risk Myelodysplastic Syndromes
Celgene
Guillermo Garcia-Manero; Valeria Santini; Antonio Almeida; Uwe Platzbecker; Anna Jonasova; Lewis R Silverman; Jose Falantes; Gianluigi Reda; Francesco Buccisano; Pierre Fenaux; Rena Buckstein; Maria Diez Campelo; Stephen Larsen; David Valcarcel; Paresh Vyas; Valentina Giai; Esther Natalie Olíva; Jake Shortt; Dietger Niederwieser; Moshe Mittelman; Luana Fianchi; Ignazia La Torre; Jianhua Zhong; Eric Laille; Daniel Lopes de Menezes; Barry Skikne; C L Beach; Aristoteles Giagounidis